Search Results - "Jeter, C"

NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation by Jeter, C R, Liu, B, Liu, X, Chen, X, Liu, C, Calhoun-Davis, T, Repass, J, Zaehres, H, Shen, J J, Tang, D G

“…Cancer cell molecular mimicry of stem cells (SC) imbues neoplastic cells with enhanced proliferative and renewal capacities. In support, numerous mediators of…”
Get full text

Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood by HIGGINS, Michaela J, JELOVAC, Danijela, EMENS, Leisha, RILEY, Carol, STEARNS, Vered, DIEHL, Frank, ANGENENDT, Philipp, PENG HUANG, COPE, Leslie, ARGANI, Pedram, MURPHY, Kathleen M, BACHMAN, Kurtis E, BARNATHAN, Evan, GRESHOCK, Joel, WOLFF, Antonio C, PARK, Ben H, BLAIR, Brian, SLATER, Shannon, POWERS, Penny, ZORZI, Jane, JETER, Stacie C, OLIVER, George R, FETTING, John

“…We sought to evaluate the feasibility of detecting PIK3CA mutations in circulating tumor DNA (ctDNA) from plasma of patients with metastatic breast cancer…”
Get full text

Self-Selection of Auditors and Audit Pricing in Private Firms by Chaney, Paul K., Jeter, Debra C., Shivakumar, Lakshmanan

“…Prior research has examined audit pricing for publicly held firms and provided some evidence of a Big 8 premium in pricing. We investigate audit pricing among…”
Get full text

A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial by Santa-Maria, Cesar A., Bardia, Aditya, Blackford, Amanda L., Snyder, Claire, Connolly, Roisin M., Fetting, John H., Hayes, Daniel F., Jeter, Stacie C., Miller, Robert S., Nguyen, Anne, Quinlan, Katie, Rosner, Gary L., Slater, Shannon, Storniolo, Anna Maria, Wolff, Antonio C., Zorzi, Jane, Henry, Nora Lynn, Stearns, Vered

“…Purpose Aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) are common adverse events of AIs often leading to drug discontinuation. We initiated a…”
Get full text

Are CSR Disclosures Value Relevant? Cross-Country Evidence by Cahan, Steven F., De Villiers, Charl, Jeter, Debra C., Naiker, Vic, Van Staden, Chris J.

“…Using proprietary data that rate corporate social responsibility (CSR) disclosures of firms in 21 countries, this study examines how the strength of…”
Get full text

Auditor Industry Specialization and Evidence of Cost Efficiencies in Homogenous Industries by Bills, Kenneth L., Jeter, Debra C., Stein, Sarah E.

“…This study examines the audit pricing effects when auditors specialize in industries conducive to transferable audit processes. Our results indicate that…”
Get full text

TBCRC 008: early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer by Connolly, Roisin M, Leal, Jeffrey P, Goetz, Matthew P, Zhang, Zhe, Zhou, Xian C, Jacobs, Lisa K, Mhlanga, Joyce, O, Joo H, Carpenter, John, Storniolo, Anna Maria, Watkins, Stanley, Fetting, John H, Miller, Robert S, Sideras, Kostandinos, Jeter, Stacie C, Walsh, Bridget, Powers, Penny, Zorzi, Jane, Boughey, Judy C, Davidson, Nancy E, Carey, Lisa A, Wolff, Antonio C, Khouri, Nagi, Gabrielson, Edward, Wahl, Richard L, Stearns, Vered

“…Epigenetic modifiers, including the histone deacetylase inhibitor vorinostat, may sensitize tumors to chemotherapy and enhance outcomes. We conducted a…”
Get full text

A Clinicopathologic Analysis of 45 Patients With Metaplastic Breast Carcinoma by Cimino-Mathews, Ashley, Verma, Sangita, Figueroa-Magalhaes, Maria Cristina, Jeter, Stacie C., Zhang, Zhe, Argani, Pedram, Stearns, Vered, Connolly, Roisin M.

“…Objectives: Metaplastic breast carcinomas (MBCs) are rare, aggressive cancers lacking targeted therapy. Here, we review the clinicopathologic features,…”
Get full text

Surveillance results from the first West Nile virus transmission season in Florida, 2001 by Blackmore, Carina G M, Stark, Lillian M, Jeter, William C, Oliveri, Robin L, Brooks, Robert G, Conti, Lisa A, Wiersma, Steven T

“…After West Nile virus (WNV) was first detected in Florida in July 2001, intensive surveillance efforts over the following five months uncovered virus activity…”
Get more information

Racial disparities in the rate of cardiotoxicity of HER2‐targeted therapies among women with early breast cancer by Litvak, Anya, Batukbhai, Bhavina, Russell, Stuart D., Tsai, Hua‐Ling, Rosner, Gary L., Jeter, Stacie C., Armstrong, Deborah, Emens, Leisha A., Fetting, John, Wolff, Antonio C., Silhy, Raquel, Stearns, Vered, Connolly, Roisin M.

“…BACKGROUND Human epidermal growth factor receptor 2 (HER2)‐targeted therapies are highly effective at preventing breast cancer recurrence but are associated…”
Get full text

Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study by Connolly, Roisin M, Li, Huili, Jankowitz, Rachel C, Zhang, Zhe, Rudek, Michelle A, Jeter, Stacie C, Slater, Shannon A, Powers, Penny, Wolff, Antonio C, Fetting, John H, Brufsky, Adam, Piekarz, Richard, Ahuja, Nita, Laird, Peter W, Shen, Hui, Weisenberger, Daniel J, Cope, Leslie, Herman, James G, Somlo, George, Garcia, Agustin A, Jones, Peter A, Baylin, Stephen B, Davidson, Nancy E, Zahnow, Cynthia A, Stearns, Vered

“…In breast cancer models, combination epigenetic therapy with a DNA methyltransferase inhibitor and a histone deacetylase inhibitor led to reexpression of genes…”
Get full text

Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study by Visvanathan, Kala, Fackler, MaryJo S, Zhang, Zhe, Lopez-Bujanda, Zoila A, Jeter, Stacie C, Sokoll, Lori J, Garrett-Mayer, Elizabeth, Cope, Leslie M, Umbricht, Christopher B, Euhus, David M, Forero, Andres, Storniolo, Anna M, Nanda, Rita, Lin, Nancy U, Carey, Lisa A, Ingle, James N, Sukumar, Saraswati, Wolff, Antonio C

“…Purpose Epigenetic alterations measured in blood may help guide breast cancer treatment. The multisite prospective study TBCRC 005 was conducted to examine the…”
Get full text

Optimizing the Use of Gene Expression Profiling in Early-Stage Breast Cancer by Kim, Hyun-Seok, Umbricht, Christopher B, Illei, Peter B, Cimino-Mathews, Ashley, Cho, Soonweng, Chowdhury, Nivedita, Figueroa-Magalhaes, Maria Cristina, Pesce, Catherine, Jeter, Stacie C, Mylander, Charles, Rosman, Martin, Tafra, Lorraine, Turner, Bradley M, Hicks, David G, Jensen, Tyler A, Miller, Dylan V, Armstrong, Deborah K, Connolly, Roisin M, Fetting, John H, Miller, Robert S, Park, Ben Ho, Stearns, Vered, Visvanathan, Kala, Wolff, Antonio C, Cope, Leslie

“…Purpose Gene expression profiling assays are frequently used to guide adjuvant chemotherapy decisions in hormone receptor-positive, lymph node-negative breast…”
Get full text

Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple-Negative Breast Cancer by Parsons, Heather A, Beaver, Julia A, Cimino-Mathews, Ashley, Ali, Siraj M, Axilbund, Jennifer, Chu, David, Connolly, Roisin M, Cochran, Rory L, Croessmann, Sarah, Clark, Travis A, Gocke, Christopher D, Jeter, Stacie C, Kennedy, Mark R, Lauring, Josh, Lee, Justin, Lipson, Doron, Miller, Vincent A, Otto, Geoff A, Rosner, Gary L, Ross, Jeffrey S, Slater, Shannon, Stephens, Philip J, VanDenBerg, Dustin A, Wolff, Antonio C, Young, Lauren E, Zabransky, Daniel J, Zhang, Zhe, Zorzi, Jane, Stearns, Vered, Park, Ben H

“…The clinical utility of next-generation sequencing (NGS) in breast cancer has not been demonstrated. We hypothesized that we could perform NGS of a new biopsy…”
Get full text

Prospective evaluation of finger two-point discrimination and carpal tunnel syndrome among women with breast cancer receiving adjuvant aromatase inhibitor therapy by Sheng, Jennifer Y., Blackford, Amanda L., Bardia, Aditya, Venkat, Raghunandan, Rosson, Gedge, Giles, Jon, Hayes, Daniel F., Jeter, Stacie C., Zhang, Zhe, Hayden, Jill, Nguyen, Anne, Storniolo, Anna Maria, Tarpinian, Karineh, Henry, Norah Lynn, Stearns, Vered

“…Purpose Aromatase inhibitors (AIs) are associated with musculoskeletal symptoms and risk of developing carpal tunnel syndrome (CTS), which can impair quality…”
Get full text

Auditor Specialization, Auditor Dominance, and Audit Fees: The Role of Investment Opportunities by Cahan, Steven F., Godfrey, Jayne M., Hamilton, Jane, Jeter, Debra C.

“…A report issued by the U.S. General Accounting Office (GAO) in 2003 identified auditors' industry expertise as a critical factor for firms choosing an auditor,…”
Get full text

Adjuvant radiation use in older women with early-stage breast cancer at Johns Hopkins by Pollock, YaoYao G., Blackford, Amanda L., Jeter, Stacie C., Wright, Jean, Cimino-Mathews, Ashley, Camp, Melissa, Harvey, Susan, Asrari, Fariba, Schoenborn, Nancy L., Stearns, Vered

“…Purpose In 2004, The National Comprehensive Cancer Network (NCCN) Guidelines incorporated omission of radiation therapy after breast-conservation surgery in…”
Get full text

The effect of reporting restructuring charges on analysts’ forecast revisions and errors by Chaney, Paul K., Hogan, Chris E., Jeter, Debra C.

“…The frequency and magnitude of restructuring charges have drawn the attention of various groups of users of accounting information. Prior studies on…”
Get full text

Myeloid toxicity in breast cancer patients receiving adjuvant chemotherapy with pegfilgrastim support by Wolff, Antonio C, Jones, Richard J, Davidson, Nancy E, Jeter, Stacie C, Stearns, Vered

Get full text

The impact on the market for audit services of aggressive competition by auditors by Chaney, Paul K., Jeter, Debra C., Erickson Shaw, Pamela

“…Supporters of direct uninvited solicitation activities argue that clients can make more informed choices of auditors when auditors are allowed to solicit…”
Get full text